Respiratory failure due to muscle weakness in inflammatory myopathies: Maintenance therapy with home mechanical ventilation

Rheumatology

Volumn 39, Issue 8, 2000, Pages 914-916

  Selva O'Callaghan, A ^a,b   Sanchez Sitjes, L ^a   Munoz Gall X ^a   Mijares Boeckh Behrens, T ^a   Solans Laque, R ^a   Bosch Gil, J Angel ^a   Morell Brotad, F ^a   Vilardell Tarrés, Miguel ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b NONE   (Spain)

Author keywords

Evaluation of new systems of care; Polymyositis dermatomyositis; Pulmonary

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; FEMALE; HOME CARE; HUMAN; HYPOVENTILATION; IMMUNOSUPPRESSIVE TREATMENT; INTERMITTENT POSITIVE PRESSURE VENTILATION; MAINTENANCE THERAPY; MALE; MUSCLE WEAKNESS; MYOPATHY; POLYMYOSITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FAILURE; TREATMENT FAILURE;

EID: 0033845941     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/39.8.914     Document Type: Article

References (20)

1. Polymyositis and dermatomyositis (parts 1 and 2)
2. Classification and prognosis of inflammatory muscle disease
3. Inclusion body myositis and myopathies
4. Life-threatening complications of autoimmune disease. Evaluation and treatment of respiratory failure in neuromuscular disease
5. Treatment of inflammatory myopathies
6. Pulmonary disease in polymyositis/dermatomyositis
7. Pulmonary disease in polymyositis/dermatomyositis: A clinicopathological analysis of 65 autopsy cases
8. Pulmonary involvement in PM/DM [abstract]
9. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings
10. Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement
11. Pulmonary involvement in poly-myositis and in dermatomyositis
12. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define a useful homogeneous patient group
13. Dyspnea and muscle weakness in a 65-year-old woman
14. Fatal respiratory failure due to polymyositis
15. Polymyositis presenting with respiratory failure
16. Inclusion body myositis as a cause of respiratory failure
17. Measurements of maximum respiratory pressures in polymyositis and dermatomyositis
18. Current concepts: Noninvasive ventilation
19. Treatment of muscular dystrophies and inflammatory myopathies
20. Mechanisms underlying effects of nocturnal ventilation on daytime blood gases in neuromuscular diseases